Xiangjun Shi
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Reactivating exhausted tumor-infiltrating T cells by a bispecific DC-T cell engager in mice.
Journal: Nature communications
Published: May 13, 2025
Alkaline phosphatase predicts short-term postoperative outcome in adult patients with moyamoya disease.
Journal: Frontiers in neurology
Published: May 07, 2025
Circulating T cell atlas in Moyamoya disease: insights into immunopathogenesis of cerebrovascular disorders.
Journal: Journal of neuroinflammation
Published: April 17, 2025
Wound healing after surgical therapy for multiple myeloma: a case-control study.
Journal: Journal of wound care
Published: October 31, 2024
Case report: Dual-targeted BCMA and CS1 CAR-T-cell immunotherapy in recurrent and refractory extramedullary multiple myeloma.
Journal: Frontiers in immunology
Published: April 24, 2024
KIAA1429 increases FOXM1 expression through YTHDF1-mediated m6A modification to promote aerobic glycolysis and tumorigenesis in multiple myeloma.
Journal: Cell biology and toxicology
Published: November 14, 2023
Myeloma extracellular vesicle-derived RAGE increases inflammatory responses and myotube atrophy in multiple myeloma through activation of the TLR4/NF-κB p65 pathway.
Journal: Apoptosis : an international journal on programmed cell death
Published: November 06, 2023
Biological research on the occurrence and development of multiple myeloma and its treatment.
Journal: Immunity, inflammation and disease
Published: February 06, 2023
Investigation of the Underlying Mechanism of Sclerosteosis Expression in Muscle Tissue in Multiple Myeloma with Sarcopenia.
Journal: Journal of inflammation research
Published: October 10, 2022
Last Updated: 09/26/2026